A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Hoofdauteur: | Islam, Nahidul |
---|---|
Andere auteurs: | Talukder, Mesbah |
Formaat: | Thesis |
Taal: | English |
Gepubliceerd in: |
Brac University
2023
|
Onderwerpen: | |
Online toegang: | http://hdl.handle.net/10361/22025 |
Gelijkaardige items
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
door: Afroza, Halima
Gepubliceerd in: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
door: Moya, Amena Khatun
Gepubliceerd in: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
door: Bishakha, Adwiza Chakraborty
Gepubliceerd in: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
door: Islam, S.M. Zahidul
Gepubliceerd in: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
door: Khandker, Tahia Anjum
Gepubliceerd in: (2024)